文献速递慢性肾脏病肾血管病与高血压

慢性肾脏病合并显著冠心病患者血钾水平与心脏性猝死风险

Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease.
PubMed 文献 · Kidney Int Rep · 2017-07-17

本研究在6181例eGFR≤60 ml/min/1.73 m²且未透析的冠心病患者中,分析血钾与心脏骤停/心脏性猝死(SCA/SCD)的关联。基线血钾异常与SCA/SCD无显著关联,但事件前血钾>5 mEq/l与SCA/SCD风险加倍相关(aOR 2.37,95%CI 1.33-4.23)。

要点

  • 事件前高钾血症(>5 mEq/l)与SCA/SCD风险独立相关。
  • 基线血钾异常未显示与SCA/SCD或全因死亡显著相关。
  • CKD合并冠心病患者应早期识别并处理高钾血症。

核心结论

  • 在CKD合并显著冠心病患者中,事件前血钾>5 mEq/l与SCA/SCD短期风险增加相关。

研究设计与样本

  • 回顾性队列研究,纳入1999-2011年接受心导管术的22009例患者中6181例eGFR≤60 ml/min/1.73 m²且未透析者。
  • 基线分析采用协变量调整Cox模型,事件前分析采用倾向评分匹配的病例对照设计。

主要发现

  • 基线高钾血症(>5 mEq/l)或低钾血症(<3.5 mEq/l)与SCA/SCD或全因死亡无显著风险关联。
  • 事件前高钾血症发生率16.7%,低钾血症3%。
  • 事件前高钾血症与SCA/SCD风险加倍相关(调整OR 2.37;95%CI 1.33-4.23)。
  • 事件前低钾血症与SCA/SCD无显著关系。

临床怎么用

  • 对CKD合并冠心病患者,应监测血钾并及时治疗高钾血症以降低SCD风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic kidney disease (CKD) patients have increased risks of sudden cardiac arrest and sudden cardiac death (SCA/SCD) that are not explained by traditional risk factors. We examined associations between serum potassium and SCA/SCD in a large cohort of patients with coronary artery disease (CAD) and moderate CKD. METHODS: Among 22,009 patients who underwent cardiac catheterization at our institution between 1999 and 2011, 6181 patients had an estimated glomerular filtration rate of ≤60 ml/min per 1.73 m2 and were not receiving renal replacement therapy. The risk of SCA/SCD and all-cause mortality associated with potassium concentration was evaluated at the time of cardiac catheterization (baseline) and most proximate to SCA/SCD events. Covariate-adjusted Cox models were used to examine relationships between baseline potassium measurements and outcomes. A propensity score-matched, case-control design was used to assess risk associations of potassium measurements obtained proximate to SCA events. RESULTS: In the baseline potassium analysis, compared with levels in the normal range, there was no significant risk association between hyperkalemia (>5 mEq/l) or hypokalemia (<3.5 mEq/l) and SCA/SCD or all-cause death after covariate adjustment. In the proximate potassium analysis, hyperkalemia occurred more frequently than hypokalemia (16.7% vs. 3%), and was associated with a doubling in SCA/SCD risk (adjusted odd ratio: 2.37; 95% confidence interval: 1.33-4.23) whereas there was no significant relationship between hypokalemia and outcome. DISCUSSION: Among CKD patients with significant CAD, elevated serum potassium levels >5.0 mEq/l are common and are associated with an increased short-term risk of SCA/SCD. Early detection and treatment of hyperkalemia may reduce the high risk of SCD among CKD patients.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Pun PH, Goldstein BA, Gallis JA, et al. Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease. Kidney Int Rep. 2017. PMID: 29270520. doi:10.1016/j.ekir.2017.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。